Skip to main content

LAP Pressure estimation in Atrial Fibrillation

 


LAP Pressure estimation in Atrial Fibrillation 

Left Atrial Pressure (LAP) Estimation in Atrial Fibrillation


Introduction


Estimating Left Atrial Pressure (LAP) in patients with atrial fibrillation (AF) is challenging because of:


Beat-to-beat variability


Absence of organized atrial contraction


Variable RR intervals


Fusion of Doppler signals



Despite these limitations, echocardiography remains useful for noninvasive LAP estimation.



---


Challenges in AF


1. No A wave on transmitral Doppler



2. Marked respiratory and cycle length variation



3. Variable preload



4. Difficulty averaging measurements



5. Tissue Doppler variability





---


General Principles


Use averages of 5–10 consecutive beats


Prefer beats with similar RR intervals


Avoid post-ectopic beats


Combine multiple parameters rather than relying on one index




---


Echocardiographic Parameters for LAP Estimation


1. Mitral Inflow Doppler


E Wave Velocity


High E velocity suggests elevated LAP.


E >1.0–1.2 m/s may indicate increased filling pressures



In AF, only E wave is present because atrial contraction is absent.


Deceleration Time (DT)


Short DT suggests elevated LAP and reduced LV compliance.


DT <160 ms → elevated LAP likely




---


2. Tissue Doppler Imaging (TDI)


Septal/Lateral e′ Velocity


Reduced e′ suggests impaired relaxation.


E/e′ Ratio


Most commonly used parameter in AF.


E/e' = \frac{\text{Mitral E velocity}}{e'}


Interpretation in AF:


Average E/e′ >14 → elevated LAP likely


Septal E/e′ often preferred


Use averaged measurements over multiple beats



Limitations:


Less reliable in significant MR, MAC, paced rhythm, or regional dysfunction




---


3. Pulmonary Vein Doppler


Useful adjunctive parameter.


Findings suggesting elevated LAP:


Blunted systolic flow


Dominant diastolic flow


Increased pulmonary vein D wave



AF limits interpretation because atrial reversal wave is absent.



---


4. Left Atrial Volume Index (LAVI)


Chronic elevation of LAP enlarges the LA.


LAVI = \frac{LA\ Volume}{BSA}


LAVI >34 mL/m² suggests chronically elevated filling pressures



However:


AF itself enlarges LA independent of LAP


Better for chronic rather than acute pressure estimation




---


5. Tricuspid Regurgitation Velocity (TR Vmax)


Elevated pulmonary pressures may indirectly indicate elevated LAP.


TR velocity >2.8 m/s supports elevated LV filling pressure




---


6. Pulmonary Artery Pressure


Elevated PASP may support chronic LAP elevation when other causes of pulmonary hypertension are excluded.



---


Integrated Approach in AF


No single parameter is sufficient.


Best practical approach:


Elevated LAP likely if multiple are present:


1. High mitral E velocity



2. Short DT



3. Average E/e′ >14



4. Enlarged LA



5. Elevated TR velocity



6. Pulmonary vein systolic blunting





---


ASE/EACVI Recommendations


The American Society of Echocardiography and European Association of Cardiovascular Imaging recommend an integrated multiparametric approach for AF because standard diastolic algorithms are less reliable in irregular rhythms.



---


Practical Tips


1. Average multiple cardiac cycles



2. Use index beats with similar RR intervals



3. Avoid relying solely on E/e′



4. Correlate with symptoms and BNP



5. Consider invasive hemodynamics when uncertainty persists





---


Invasive Gold Standard


Direct LAP or PCWP measurement during catheterization remains the gold standard when noninvasive findings are inconclusive.



---


Key Takeaway


In atrial fibrillation, LAP estimation requires integration of:


Mitral inflow


Tissue Doppler


LA size


TR velocity


Pulmonary vein flow



Among these, averaged E/e′ ratio combined with LA enlargement and elevated TR velocity provides the most practical noninvasive assessment of elevated filling pressures.



Comments

Popular posts from this blog

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

2025 AHA/ACC Hypertension Guidelines Key points

  2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...